This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

40 Hedge Funds' Best Stocks Show the Way for 2012 (Update 1)

Health Care

The health care sector was a popular one in the fourth quarter for hedge fund managers looking for merger-arbitrage opportunities. Takeover targets like Kinetic Concepts, Adolor and Pharmasset were snatched up during the quarter, increasing health care weightings for several hedge fund managers.

The merger activity is one way to explain the strong performance of the health care sector this year. Health care names in the S&P 500 rose 10.2% overall last year, according to S&P Capital IQ, the third best sector performance this year. The outlook for health care stocks, though, leaves plenty to be desired. After notching only 4.6% earnings growth in the fourth quarter, analysts are calling for 2.4% earnings growth for the sector in all of 2012. Health care stocks are trailing the broader indices this year, climbing only 3.8% in 2012 through Feb. 15.

David Tepper of Appaloosa Management was a buyer of health care stocks, picking up nearly 8 million shares of Boston Scientific (BSX). Ray Dalio was another buyer, with his Bridgewater Associates hedge fund buying shares of Johnson & Johnson (JNJ), Watson Pharmaceuticals (WPI) and St. Jude Medical (STJ), among others.

Louis Bacon of Moore Capital was also a big health care buyer, picking up shares of Gilead Sciences (GILD), Express Script (ESRX), Cigna (CI) and WellPoint (WLP), among several others.

Renaissance Technologies, the world's largest quant fund, also upped its exposure to health care, adding to stakes in Gilead, Thermo Fisher (TMO), Humana (HUM), Intuitive Surgical (ISRG) and Cigna, among others.

Not all were buyers, however. Barry Rosenstein's Jana Partners liquidated a position in Covidien (COV) and nearly dumped its entire stake in HCA Holdings (HCA).

>>To see these stocks in action, visit the Health Care Stocks Bought and Sold by Hedge Funds portfolio on Stockpickr.
7 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $125.42 0.72%
BAC $17.02 0.77%
C $55.24 0.66%
GOOG $520.51 -0.19%
SIRI $3.73 0.54%

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.12 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs